| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |